You just read:

Health Canada Approves Bexsero*, the First Vaccine Available to Prevent Meningococcal Serogroup B (MenB)(1,2)

News provided by

Novartis Pharmaceuticals Canada Inc.

Dec 09, 2013, 01:15 ET